Magnetization transfer MRI in multiple sclerosis

Journal of Neuroimaging

Volumn 17, Issue SUPPL. 1, 2007, Pages

  Filippi, Massimo ^a,b   Agosta, Federica ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

Magnetic resonance imaging; Magnetization transfer MRI; Multiple sclerosis

Indexed keywords

CENTRAL NERVOUS SYSTEM; COMPREHENSION; DEMYELINATING DISEASE; DIAGNOSTIC ACCURACY; DISEASE COURSE; HUMAN; IN VIVO STUDY; INFORMATION; MENTAL DEFICIENCY; MONITORING; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; QUANTITATIVE ANALYSIS; REVIEW; TISSUE INJURY; WHITE MATTER;

CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS;

EID: 34147186825     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2007.00132.x     Document Type: Review

References (68)

1. Filippi M, Rocca MA. Magnetization transfer magnetic resonance imaging in the assessment of neurological diseases. J Neuroimaging 2004;14:303-313.
2. Filippi M, Grossman RI. MRI techniques to monitor MS evolution: the present and the future. Neurology 2002;58:1147-1153.
3. Wolff SD, Balaban RS. Magnetization transfer imaging: practical aspects and clinical applications. Radiology 1994;192:593-599.
4. van Buchem MA, McGowan JC, Kolson DL, et al. Quantitative volumetric magnetization transfer analysis in multiple sclerosis: estimation of macroscopic and microscopic disease burden. Magn Reson Med 1996;36:632-636.
5. van Waesberghe JH, Kamphorst W, De Groot C, et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 1999;46:747-754.
6. Schmierer K, Scaravilli F, Altmann DR, et al. Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann Neurol 2004;56:407-415.
7. Lai HM, Davie CA, Gass A, et al. Serial magnetization transfer ratios in gadolinium-enhancing lesions in multiple sclerosis. J Neurol 1997;244:308-311.
8. Dousset V, Gayou A, Brochet B, et al. Early structural changes in acute MS lesions assessed by serial magnetization transfer studies. Neurology 1998;51:1150-1155.
9. Filippi M, Rocca MA, Rizzo G, et al. Magnetization transfer ratios in multiple sclerosis lesions enhancing after different doses of gadolinium. Neurology 1998;50:1289-1293.
10. Filippi M, Rocca MA, Martino G, et al. Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann Neurol 1998;43:809-814.
11. Goodkin DE, Rooney WD, Sloan R, et al. A serial study of new MS lesions and the white matter from which they arise. Neurology 1998;51:1689-1697.
12. Silver NC, Lai M, Symms MR, et al. Serial magnetization transfer imaging to characterize the early evolution of new MS lesions. Neurology 1998;51:758-764.
13. van Waesberghe JH, van Walderveen MA, Castelijns JA, et al. Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization MR. AJNR Am J Neuroradiol 1998;19:675-683.
14. Rocca MA, Mastronardo G, Rodegher M, et al. Long-term changes of magnetization transfer-derived measures from patients with relapsing-remitting and secondary progressive multiple sclerosis. AJNR Am J Neuroradiol 1999;20:821-827.
15. Katz D, Taubenberger JK, Cannella B, et al. Correlation between magnetic resonance imaging findings and lesion development in multiple sclerosis. Ann Neurol 1993;34:661-669.
16. Lassmann H, Suchanek G, Ozawa K. Histopathology and the blood-cerebrospinal fluid barrier in multiple sclerosis. Ann Neurol 1994;36(suppl 1):42-46.
17. Gass A, Barker GJ, Kidd D, et al. Correlation of magnetization transfer ratio with disability in multiple sclerosis. Ann Neurol 1994;36:62-67.
18. van Walderveen MA, Kamphorst W, Scheltens P, et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology 1998;50:1282-1288.
19. Hiehle JF, Grossman RI, Ramer NK, et al. Magnetization transfer effects in MR-detected multiple sclerosis lesions: comparison with gadolinium-enhanced spin-echo images and non-enhanced T1-weighted images. AJNR Am J Neuroradiol 1995;16:69-77.
20. Filippi M, Iannucci G, Tortorella C, et al. Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI. Neurology 1999;52:588-594.
21. Iannucci G, Tortorella C, Rovaris M, et al. Prognostic value of MR and magnetization transfer imaging findings in patients with clinically isolated syndromes suggestive of multiple sclerosis at presentation. AJNR Am J Neuroradiol 2000;21:1034-1038.
22. De Stefano N, Battaglini M, Stromillo ML, et al. Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis. Brain 2006;129:2008-2016.
23. Rovaris M, Bozzali M, Santuccio G, et al. In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis. Brain 2001;124:2540-2549.
24. Rocca MA, Falini A, Colombo B, et al. Adaptive functional changes in the cerebral cortex of patients with nondisabling MS correlate with the extent of brain structural damage. Ann Neurol 2002;51:330-339.
25. Pike GB, De Stefano N, Narayanan S, et al. Multiple sclerosis: magnetization transfer MR imaging of white matter before lesion appearance on T2-weighted images. Radiology 2000;215:824-830.
26. Fazekas F, Ropele S, Enzinger C, et al. Quantitative magnetization transfer imaging of pre-lesional white-matter changes in multiple sclerosis. Mult Scler 2002;8:479-484.
27. Laule C, Vavasour IM, Whittall KP, et al. Evolution of focal and diffuse magnetisation transfer abnormalities in multiple sclerosis. J Neurol 2003;250:924-931.
28. Vrenken H, Geurts JJ, Knol DL, et al. Normal-appearing white matter changes vary with distance to lesions in multiple sclerosis. AJNR Am J Neuroradiol 2006;27:2005-2011.
29. Dehmeshki J, Silver NC, Leary SM, et al. Magnetisation transfer ratio histogram analysis of primary progressive and other multiple sclerosis subgroups. J Neurol Sci 2001;185:11-17.
30. Kalkers NF, Hintzen RQ, van Waesberghe JH, et al. Magnetization transfer histogram parameters reflect all dimensions of MS pathology, including atrophy. J Neurol Sci 2001;184:155-162.
31. Ge Y, Grossman RI, Udupa JK, et al. Magnetization transfer ratio histogram analysis of normal-appearing gray matter and normal-appearing white matter in multiple sclerosis. J Comput Assist Tomogr 2002;26:62-68.
32. Traboulsee A, Dehmeshki J, Brex PA, et al. Normal-appearing brain tissue MTR histograms in clinically isolated syndromes suggestive of MS. Neurology 2002;59:126-128.
33. Davies GR, Altmann DR, Hadjiprocopis A, et al. Increasing normal-appearing grey and white matter magnetisation transfer ratio abnormality in early relapsing-remitting multiple sclerosis. J Neurol 2005;252:1037-1044.
34. Fernando KT, Tozer DJ, Miszkiel KA, et al. Magnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis. Brain 2005;128:2911-2925.
35. Ramio-Torrenta L, Sastre-Garriga J, Ingle GT, et al. Abnormalities in normal appearing tissues in early primary progressive multiple sclerosis and their relation to disability: a tissue specific magnetisation transfer study. J Neurol Neurosurg Psychiatry 2006;77:40-45.
36. Iannucci G, Minicucci L, Rodegher M, et al. Correlations between clinical and MRI involvement in multiple sclerosis: assessment using T1, T2 and MT histograms. J Neurol Sci 1999;171:121-129.
37. Dehmeshki J, Ruto AC, Arridge S, et al. Analysis of MTR histograms in multiple sclerosis using principal components and multiple discriminant analysis. Magn Reson Med 2001;46:600-609.
38. Traboulsee A, Dehmeshki J, Peters KR, et al. Disability in multiple sclerosis is related to normal appearing brain tissue MTR histogram abnormalities. Mult Scler 2003;9:566-573.
39. Ranjeva JP, Audoin B, Au Duong MV, et al. Local tissue damage assessed with statistical mapping analysis of brain magnetization transfer ratio: relationship with functional status of patients in the earliest stage of multiple sclerosis. AJNR Am J Neuroradiol 2005;26:119-127.
40. Rovaris M, Filippi M, Falautano M, et al. Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis. Neurology 1998;50:1601-1608.
41. van Buchem MA, Grossman RI, Armstrong C, et al. Correlation of volumetric magnetization transfer imaging with clinical data in MS. Neurology 1998;50:1609-1617.
42. Filippi M, Tortorella C, Rovaris M, et al. Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis. J Neurol Neurosurg Psychiatry 2000;68:157-161.
43. Cox D, Pelletier D, Genain C, et al. The unique impact of changes in normal appearing brain tissue on cognitive dysfunction in secondary progressive multiple sclerosis patients. Mult Scler 2004;10:626-629.
44. Deloire MS, Salort E, Bonnet M, et al. Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2005;76:519-526.
45. Kaiser JS, Grossman RI, Polansky M, et al. Magnetization transfer histogram analysis of monosymptomatic episodes of neurologic dysfunction: preliminary findings. AJNR Am J Neuroradiol 2000;21:1043-1047.
46. Brex PA, Leary SM, Plant GT, et al. Magnetization transfer imaging in patients with clinically isolated syndromes suggestive of multiple sclerosis. AJNR Am J Neuroradiol 2001;22:947-951.
47. Santos AC, Narayanan S, de Stefano N, et al. Magnetization transfer can predict clinical evolution in patients with multiple sclerosis. J Neurol 2002;249:662-668.
48. Rovaris M, Agosta F, Sormani MP, et al. Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study. Brain 2003;126:2323-2332.
49. Tortorella C, Viti B, Bozzali M, et al. A magnetization transfer histogram study of normal appearing brain tissue in multiple sclerosis. Neurology 2000;54:186-193.
50. Iannucci G, Rovaris M, Giacomotti L, et al. Correlations between measures of multiple sclerosis pathology derived from T2, T1, magnetization transfer and diffusion tensor MR imaging. AJNR Am J Neuroradiol 2001;22:1462-1467.
51. Filippi M, Rocca MA, Falini A, et al. Correlations between structural CNS damage and functional MRI changes in primary progressive MS. Neuroimage 2002;15:537-546.
52. Audoin B, Au Duong MV, Ranjeva JP, et al. Magnetic resonance study of the influence of tissue damage and cortical reorganization on PASAT performance at the earliest stage of multiple sclerosis. Hum Brain Mapp 2005;24:216-228.
53. Cercignani M, Bozzali M, Iannucci G, et al. Magnetisation transfer ratio and mean diffusivity of normal-appearing white and gray matter from patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 2001;70:311-317.
54. Ge Y, Grossman RI, Udupa JK, et al. Magnetization transfer ratio histogram analysis of gray matter in relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol 2001;22:470-475.
55. Dehmeshki J, Chard DT, Leary SM, et al. The normal appearing gray matter in primary progressive multiple sclerosis: a magnetisation transfer imaging study. J Neurol 2003;250:67-74.
56. Audoin B, Ranjeva JP, Au Duong MV, et al. Voxel-based analysis of MTR images: a method to locate grey matter abnormalities in patients at the earliest stage of multiple sclerosis. J Magn Reson Imaging 2005;20:765-771.
57. Davies GR, Altmann DR, Rashid W, et al. Emergence of thalamic magnetization transfer ratio abnormality in early relapsing-remitting multiple sclerosis. Mult Scler 2005;11:276-281.
58. Sharma J, Zivadinov R, Jaisani Z, et al. A magnetization transfer MRI study of deep gray matter involvement in multiple sclerosis. J Nueroimaging 2006;16:302-310.
59. Davies GR, Ramio-Torrenta L, Hadjiprocopis A, et al. Evidence for gray matter MTR abnormality in minimally disabled patients with early relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2004;75:998-1002.
60. Oreja-Guevara C, Charil A, Caputo D, et al. Magnetization transfer magnetic resonance imaging reflects clinical changes over 18 months in relapsing-remitting MS patients. Arch Neurol 2006;63:736-740.
61. Rovaris M, Filippi M, Minicucci L, et al. Cortical/ subcortical disease burden and cognitive impairment in patients with multiple sclerosis. AJNR Am J Neuroradiol 2000;21:402-408.
62. Codella M, Rocca MA, Colombo B, et al. A preliminary study of magnetization transfer and diffusion tensor MRI of multiple sclerosis patients with fatigue. J Neurol 2002;249:535-537.
63. Agosta F, Rovaris M, Pagani E, et al. Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis. Brain 2006;129:2620-2627.
64. Richert ND, Ostuni JL, Bash CN, et al. Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis. Mult Scler 2001;7:49-58.
65. Kita M, Goodkin DE, Bacchetti P, et al. Magnetization transfer ratio in new MS lesions before and during therapy with IFNß-1a. Neurology 2000;54:1741-1745.
66. Fox RJ, Fisher E, Tkach J, et al. Brain atrophy and magnetization transfer ratio following methylprednisolone in multiple sclerosis: short-term changes and long-term implications. Mult Scler 2005;11:140-145.
67. Inglese M, van Waesberghe JH, Rovaris M, et al. The effect of interferon beta-1b on quantities derived from MT MRI in secondary progressive MS. Neurology 2003;60:853-860.
68. Filippi M, Rocca MA, Pagani E, et al. European study on intravenous immunoglobulin in multiple sclerosis: results of magnetization transfer magnetic resonance imaging analysis. Arch Neurol 2004;61:1409-1412.